{"id":"W2792760898","doi":"10.2217/imt-2017-0162","title":"CD19-specific Chimeric Antigen Receptor-Modified (CAR)-T cell Therapy for the Treatment of Chronic Lymphocytic Leukemia in the Ibrutinib Era","year":2018,"lang":"en","type":"editorial","venue":"Immunotherapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Chronic lymphocytic leukemia; Ibrutinib; Medicine; Chimeric antigen receptor; Leukemia; Oncology; Cancer; Immunology; Internal medicine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001541239,0.001080917,0.001732046,0.0003784774,0.0003775246,0.0001214919,0.001786327,0.001217635,0.0005209462],"category_scores_gemma":[0.0001063067,0.0005866179,0.00105213,0.0008790525,0.0008367351,0.00008977942,0.0000517738,0.0008250774,0.0001308223],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.07932212,"about_ca_system_score_gemma":0.06380812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004460128,"about_ca_topic_score_gemma":0.0001141041,"domain_scores_codex":[0.9937703,0.0004554855,0.001365906,0.001155991,0.001916406,0.001335929],"domain_scores_gemma":[0.9899448,0.005415531,0.0007207012,0.003294325,0.0005112545,0.0001134283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01317038,0.0008164279,0.000008058807,0.0003343277,0.001449617,0.00003071191,0.006694825,0.0001609457,0.009689714,0.00003738696,0.9114397,0.05616789],"study_design_scores_gemma":[0.07028996,0.007856034,0.00004961228,0.0002963952,0.00009486583,0.00001547377,0.0003855546,0.00261695,0.008015098,0.0000442103,0.9098305,0.0005054112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.1555645,0.2886347,0.0003252146,0.0005504345,0.532791,0.01929051,0.0006705196,0.0002295936,0.00194352],"genre_scores_gemma":[0.03178715,0.4694623,0.0002511836,0.0002324332,0.4902411,0.002489714,0.00100575,0.0004725291,0.004057837],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.1808275,"threshold_uncertainty_score":0.9996585,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02654790113269132,"score_gpt":0.3216215715794757,"score_spread":0.2950736704467843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}